The six most common resident cataract surgery mistakes

Learning cataract surgery during ophthalmology residency is critically important for many reasons. It is the most widely performed ophthalmic surgery, it teaches intraocular surgical techniques, it helps to develop surgical judgment, and it can restore an amazing level of vision to our patients. There are quite a few pitfalls in learning cataract surgery, and after teaching more than 100 resident ophthalmologists over the past 16 years, I have found that the same types of mistakes tend to be made early in the learning curve.Remember that it is not “just a (Read more...)

Physician assistants can enhance experience in a practice

In our practice at Minnesota Eye Consultants, we are committed to what I call an “integrated eye care delivery model.” We have 13 ophthalmologists and 13 optometrists. To support these doctors and the six offices and four ASCs we staff, Minnesota Eye Consultants employs about 55 certified ophthalmic technologists/technicians/assistants and optometric assistants, 26 RNs/LPNs, seven certified operating room technicians, six opticians and, starting 5 years ago, a physician assistant, up to three PAs today.In our practice, the PAs practice independently within our state of Minnesota’s scope of practice laws, much (Read more...)

Ophthalmologists who invest in physician assistants reap valuable rewards

Among the various physician extenders for an ophthalmic practice, a physician assistant may very well be the most valuable for patient care, patient convenience and the practice’s financial well-being due to the wide scope of services that a physician assistant can perform. However, practices must be willing to commit the time and resources necessary to properly train such a medical professional.“Having a physician assistant (PA) is a critical part of the eye care team, but not necessarily more or less valuable than having an optometric provider,” Michael L. Gilbert, MD, (Read more...)

FDA adds ocular indication for Humira, issues complete response letters

Recent FDA activity includes the addition of an ocular indication for AbbVie’s Humira and the issuance of two complete response letters, one to Ocular Therapeutix and one to Valeant, citing manufacturing concerns. Ocular Surgery News compiled these stories from Healio.com/OSN.The FDA has approved Humira for the treatment of noninfectious intermediate and posterior uveitis and panuveitis, according to a press release from AbbVie. Read more

Device converts movement to measurement

Dynamic light scattering may be used to determine whether age-related nuclear cataracts are associated with loss of a critical protein in the crystalline lens.In one study, the authors set out to corroborate a previous cross-sectional study showing th…